Cbdmd Inc Stock Today
| YCBD Stock | USD 0.47 0.02 4.08% |
Performance0 of 100
| Odds Of DistressOver 85
|
CbdMD is trading at 0.47 as of the 5th of December 2024, a 4.08 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.47. CbdMD has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for cbdMD Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of December 2022 and ending today, the 5th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 29th of April 2019 | Category Healthcare | Classification Health Care |
cbdMD, Inc. produces and distributes various cannabidiol products. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. The company has 4.47 M outstanding shares of which 205.96 K shares are at this time shorted by private and institutional investors with about 0.83 trading days to cover. More on cbdMD Inc
Moving together with CbdMD Stock
Moving against CbdMD Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
CbdMD Stock Highlights
| Principal CEO | Ronan Kennedy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Consumer Goods (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Consumer Goods, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCbdMD can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CbdMD's financial leverage. It provides some insight into what part of CbdMD's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cbdMD Inc (YCBD) is traded on NYSE MKT Exchange in USA. It is located in 8845 Red Oak Boulevard, Charlotte, NC, United States, 28217 and employs 52 people. CbdMD is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.12 M. cbdMD Inc conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 4.47 M outstanding shares of which 205.96 K shares are at this time shorted by private and institutional investors with about 0.83 trading days to cover.
cbdMD Inc currently holds about 10.55 M in cash with (4.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check CbdMD Probability Of Bankruptcy
Ownership AllocationcbdMD Inc shows 16.11 percent of its outstanding shares held by insiders and 3.32 percent owned by other corporate entities.
Check CbdMD Ownership Details
CbdMD Historical Income Statement
CbdMD Stock Against Markets
CbdMD Corporate Management
| Zeb Booker | Chief Officer | Profile | |
| Raymond Coffman | CoFounder Chairman | Profile | |
| Kevin MacDermott | President | Profile | |
| John Weston | Director Relations | Profile | |
| Shannon Charles | Chief Officer | Profile | |
| Francisco Mangual | Senior Sales | Profile |
Already Invested in cbdMD Inc?
The danger of trading cbdMD Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CbdMD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CbdMD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile cbdMD Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.52) | Revenue Per Share 7.06 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) | Return On Equity (1.35) |
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.